acrolein has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Angelopoulou, E; Mishra, A; Paudel, YN; Piperi, C | 1 |
| Chen, Z; Herr, SA; Jiao, Y; Lin, Y; Rogers, E; Shi, L; Shi, R; Tang, J | 1 |
| Acosta, G; Fernandez, J; Herr, S; Race, N; Rogers, E; Shi, R; Tang, J | 1 |
1 review(s) available for acrolein and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities.
Topics: Acrolein; Animals; Cinnamomum zeylanicum; Humans; Mice; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary | 2021 |
2 other study(ies) available for acrolein and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson's disease: implication of acrolein and TRPA1.
Topics: Acrolein; Animals; Behavior, Animal; Cerebral Cortex; Dimercaprol; Dopaminergic Neurons; Hydroxydopamines; Male; Motor Activity; Neostriatum; Neuroprotective Agents; Pain; Pain Measurement; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; TRPA1 Cation Channel | 2021 |
Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.
Topics: Acrolein; alpha-Synuclein; Animals; Brain Injuries, Traumatic; Corpus Striatum; Male; Parkinson Disease, Secondary; Protein Multimerization; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2019 |